Sign in
4

Changes in Ownership

Pyxis Oncology, Inc. Filed Acc 0001140361-21-034643

Director acquired 2,388 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
FLAVIN JOHN L Director 2021-10-13 Conversion +2,388 171,610 D
Derivatives
FLAVIN JOHN L Director 2021-10-13 Conversion · Series B Convertible Preferred Stock −15,190 0 D
Loading xslF345X03/form4.xml…